SCAN database: facilitating integrative analyses of cytosine modification and expression QTL

Functional annotation of genetic variants including single nucleotide polymorphisms (SNPs) and copy number variations (CNV) promises to greatly improve our understanding of human complex traits. Previous transcriptomic studies involving individuals from different global populations have investigated the genetic architecture of gene expression variation by mapping expression quantitative trait loci (eQTL). Functional interpretation of genome-wide association studies (GWAS) has identified enrichment of eQTL in top signals from GWAS of human complex traits. The SCAN (SNP and CNV Annotation) database was developed as a web-based resource of genetical genomic studies including eQTL detected in the HapMap lymphoblastoid cell line samples derived from apparently healthy individuals of European and African ancestry. Considering the critical roles of epigenetic gene regulation, cytosine modification quantitative trait loci (mQTL) are expected to add a crucial layer of annotation to existing functional genomic information. Here, we describe the new features of the SCAN database that integrate comprehensive mQTL mapping results generated in the HapMap CEU (Caucasian residents from Utah, USA) and YRI (Yoruba people from Ibadan, Nigeria) LCL samples and demonstrate the utility of the enhanced functional annotation system. Database URL: http://www.scandb.org/

[1]  H. Chandler.  Database , 1985 .

[2]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[3]  N. Cox,et al.  Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS , 2010, PLoS genetics.

[4]  Latarsha J. Carithers,et al.  The Genotype-Tissue Expression (GTEx) Project. , 2015, Biopreservation and biobanking.

[5]  Tyson A. Clark,et al.  Evaluation of genetic variation contributing to differences in gene expression between populations. , 2008, American journal of human genetics.

[6]  M. Eileen Dolan,et al.  Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci , 2010, Proceedings of the National Academy of Sciences.

[7]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[8]  Tammy M. Havener,et al.  A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT , 2012, Pharmacogenetics and genomics.

[9]  Keely L. Szilágyi,et al.  Exploring DNA Methylation of MYLK as a Contributor to Acute Respiratory Distress Syndrome Disparities , 2013 .

[10]  Erika L. Moen,et al.  Cancer Biology and Signal Transduction the Role of Gene Body Cytosine Modifications in Mgmt Expression and Sensitivity to Temozolomide , 2022 .

[11]  Tyson A. Clark,et al.  Genetic architecture of transcript-level variation in humans. , 2008, American journal of human genetics.

[12]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[13]  L. Hou,et al.  Pharmacogenomic Discovery Delineating the Genetic Basis of Drug Response , 2013, Current Genetic Medicine Reports.

[14]  Toshihiro Tanaka.  The International HapMap Project , 2003, Nature.

[15]  R. Redon,et al.  Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes , 2007, Science.

[16]  Xiao Zhang,et al.  Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis , 2010, BMC Bioinformatics.

[17]  D. Mannino,et al.  Race and gender differences in acute respiratory distress syndrome deaths in the United States: An analysis of multiple-cause mortality data (1979–1996)* , 2002, Critical care medicine.

[18]  Christopher D. Brown,et al.  Identification and Validation of Genetic Variants that Influence Transcription Factor and Cell Signaling Protein Levels , 2014, American journal of human genetics.

[19]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[20]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[21]  Wei Zhang,et al.  SCAN: SNP and copy number annotation , 2010, Bioinform..

[22]  Diane P. Martin,et al.  Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.

[23]  Wei Zhang,et al.  Linking the genetic architecture of cytosine modifications with human complex traits. , 2014, Human molecular genetics.

[24]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[25]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[26]  Mingyao Li,et al.  Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma* , 2008, Critical care medicine.

[27]  Wei Zhang,et al.  PACdb: a database for cell-based pharmacogenomics. , 2010, Pharmacogenetics and genomics.

[28]  Wei Zhang,et al.  Genome-Wide Variation of Cytosine Modifications Between European and African Populations and the Implications for Complex Traits , 2013, Genetics.

[29]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[30]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.